Skip to main content
SpringerLink
Log in

Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome (ARDS)

  • Chapter
  • First Online:
Pediatric Critical Care Medicine

Abstract

Acute lung injury (ALI) and its most severe manifestation of Acute Respiratory Distress Syndrome (ARDS) is a clinical syndrome of inflammation of the lung triggered by both direct (e.g. pneumonia) and indirect (e.g. sepsis) inciting events that result in the loss of the capillary-alveolar integrity. As a consequence, patients suffer from high-permeability, non-hydrostatic pulmonary edema. Compensatory mechanisms regulating lung fluid flux are overcome and interstitial and alveolar edema develops leading to reduced lung compliance and alveolar collapse. These physiologic derangements cause ventilation and perfusion (VA/Q) mismatch and consequently intrapulmonary shunting leads to hypoxemia that is the hallmark of ALI/ARDS. The incidence of ALI/ARDS places it among the most burdensome health care challenges in pediatrics. A complex interaction of cellular components, cytokine and chemokine mediators, and adhesion molecules of the immune system orchestrate the pathophysiology of ALI/ARDS. The mainstay of therapy is institution of positive pressure mechanical ventilation that requires careful attention to minimizing distending pressures responsible for ventilator-induced exacerbation of injury as well as optimal recruitment strategies to avoid repetitive opening and closing of lung units. Avoidance of fluid overload following adequate fluid resuscitation appears to be of benefit, while additional therapies such as prone positioning, corticosteroids, inhaled nitric oxide and high frequency oscillatory ventilation may improve arterial oxygenation, though none have been systematically proven to improve overall clinical outcomes in limited pediatric studies. Novel approaches to identifying new therapeutic targets for attenuating the pathophysiology of ALI/ARDS are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ashbaugh DG, Bigelow DB, Petty TL. Acute respiratory distress in adults. Lancet. 1967;2:319–23.

    CAS  PubMed  Google Scholar 

  2. Petty TL, Ashbaugh DG. The adult respiratory distress syndrome. Clinical features, factors influencing prognosis and principles of management. Chest. 1971;60(3):233–9.

    CAS  PubMed  Google Scholar 

  3. Murray JF, Matthay MA, Luce JM, Flick MR. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis. 1988;138(3):720–3.

    CAS  PubMed  Google Scholar 

  4. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994;149(3 Pt 1):818–24.

    CAS  PubMed  Google Scholar 

  5. Thomas NJ, Shaffer ML, Willson DF, Shih MC, Curley MA. Defining acute lung disease in children with the oxygenation saturation index. Pediatr Crit Care Med. 2010;11(1):12–7.

    PubMed Central  PubMed  Google Scholar 

  6. The ARDS Definition Task Force. Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012;307(23):2526–33.

    Google Scholar 

  7. Flori HR, Glidden DV, Rutherford GW, Matthay MA. Pediatric acute lung injury: prospective evaluation of risk factors associated with mortality. Am J Respir Crit Care Med. 2005;171(9):995–1001.

    PubMed  Google Scholar 

  8. Lewandowski K. Epidemiological data challenge ARDS/ALI definition. Intensive Care Med. 1999;25(9):884–6.

    CAS  PubMed  Google Scholar 

  9. Valta P, Uusaro A, Nunes S, Ruokonen E, Takala J. Acute respiratory distress syndrome: frequency, clinical course, and costs of care. Crit Care Med. 1999;27(11):2367–74.

    CAS  PubMed  Google Scholar 

  10. McIntyre Jr RC, Pulido EJ, Bensard DD, Shames BD, Abraham E. Thirty years of clinical trials in acute respiratory distress syndrome. Crit Care Med. 2000;28(9):3314–31.

    CAS  PubMed  Google Scholar 

  11. Villar J, Slutsky AS. The incidence of the adult respiratory distress syndrome. Am Rev Respir Dis. 1989;140(3):814–6.

    CAS  PubMed  Google Scholar 

  12. Goh AY, Chan PW, Lum LC, Roziah M. Incidence of acute respiratory distress syndrome: a comparison of two definitions. Arch Dis Child. 1998;79(3):256–9.

    CAS  PubMed Central  PubMed  Google Scholar 

  13. Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, et al. Incidence and outcomes of acute lung injury. N Engl J Med. 2005;353(16):1685–93.

    CAS  PubMed  Google Scholar 

  14. West J. Respiratory physiology: the essentials. Baltimore: Williams & Wilkins; 1991.

    Google Scholar 

  15. Pelosi P, Caironi P, Gattinoni L. Pulmonary and extrapulmonary forms of acute respiratory distress syndrome. Semin Respir Crit Care Med. 2001;22(3):259–68.

    CAS  PubMed  Google Scholar 

  16. Gattinoni L, Pelosi P, Suter PM, Pedoto A, Vercesi P, Lissoni A. Acute respiratory distress syndrome caused by pulmonary and extrapulmonary disease. Different syndromes? Am J Respir Crit Care Med. 1998;158(1):3–11.

    CAS  PubMed  Google Scholar 

  17. Pelosi P, Gattinoni L. Acute respiratory distress syndrome of pulmonary and extra-pulmonary origin: fancy or reality? Intensive Care Med. 2001;27(3):457–60.

    CAS  PubMed  Google Scholar 

  18. Pelosi P, Goldner M, McKibben A, Adams A, Eccher G, Caironi P, et al. Recruitment and derecruitment during acute respiratory failure: an experimental study. Am J Respir Crit Care Med. 2001;164(1):122–30.

    CAS  PubMed  Google Scholar 

  19. Eisner MD, Thompson T, Hudson LD, Luce JM, Hayden D, Schoenfeld D, et al. Efficacy of low tidal volume ventilation in patients with different clinical risk factors for acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med. 2001;164(2):231–6.

    CAS  PubMed  Google Scholar 

  20. Paret G, Ziv T, Barzilai A, Ben-Abraham R, Vardi A, Manisterski Y, et al. Ventilation index and outcome in children with acute respiratory distress syndrome. Pediatr Pulmonol. 1998;26(2):125–8.

    CAS  PubMed  Google Scholar 

  21. Davis SL, Furman DP, Costarino Jr AT. Adult respiratory distress syndrome in children: associated disease, clinical course, and predictors of death. J Pediatr. 1993;123(1):35–45.

    CAS  PubMed  Google Scholar 

  22. Bojko T, Notterman DA, Greenwald BM, De Bruin WJ, Magid MS, Godwin T. Acute hypoxemic respiratory failure in children following bone marrow transplantation: an outcome and pathologic study. Crit Care Med. 1995;23(4):755–9.

    CAS  PubMed  Google Scholar 

  23. Fein AM, Lippmann M, Holtzman H, Eliraz A, Goldberg SK. The risk factors, incidence, and prognosis of ARDS following septicemia. Chest. 1983;83(1):40–2.

    CAS  PubMed  Google Scholar 

  24. Hudson LD, Milberg JA, Anardi D, Maunder RJ. Clinical risks for development of the acute respiratory distress syndrome. Am J Respir Crit Care Med. 1995;151(2 Pt 1):293–301.

    CAS  PubMed  Google Scholar 

  25. Pepe PE, Potkin RT, Reus DH, Hudson LD, Carrico CJ. Clinical predictors of the adult respiratory distress syndrome. Am J Surg. 1982;144(1):124–30.

    CAS  PubMed  Google Scholar 

  26. Doyle RL, Szaflarski N, Modin GW, Wiener-Kronish JP, Matthay MA. Identification of patients with acute lung injury. Predictors of mortality. Am J Respir Crit Care Med. 1995;152(6 Pt 1):1818–24.

    CAS  PubMed  Google Scholar 

  27. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med. 2000;342(18):1334–49.

    CAS  PubMed  Google Scholar 

  28. Kaplan RL, Sahn SA, Petty TL. Incidence and outcome of the respiratory distress syndrome in gram-negative sepsis. Arch Intern Med. 1979;139(8):867–9.

    CAS  PubMed  Google Scholar 

  29. Timmons OD, Dean JM, Vernon DD. Mortality rates and prognostic variables in children with adult respiratory distress syndrome. J Pediatr. 1991;119(6):896–9.

    CAS  PubMed  Google Scholar 

  30. DeBruin W, Notterman DA, Magid M, Godwin T, Johnston S. Acute hypoxemic respiratory failure in infants and children: clinical and pathologic characteristics. Crit Care Med. 1992;20(9):1223–34.

    CAS  PubMed  Google Scholar 

  31. Holbrook PR, Taylor G, Pollack MM, Fields AI. Adult respiratory distress syndrome in children. Pediatr Clin North Am. 1980;27(3):677–85.

    CAS  PubMed  Google Scholar 

  32. Bowler RP, Duda B, Chan ED, Enghild JJ, Ware LB, Matthay MA, et al. Proteomic analysis of pulmonary edema fluid and plasma in patients with acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2004;286(6):L1095–104.

    CAS  PubMed  Google Scholar 

  33. Olman MA, White KE, Ware LB, Simmons WL, Benveniste EN, Zhu S, et al. Pulmonary edema fluid from patients with early lung injury stimulates fibroblast proliferation through IL-1{beta}-induced IL-6 expression. J Immunol. 2004;172(4):2668–77.

    CAS  PubMed  Google Scholar 

  34. Rosseau S, Hammerl P, Maus U, Walmrath HD, Schutte H, Grimminger F, et al. Phenotypic characterization of alveolar monocyte recruitment in acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol. 2000;279(1):L25–35.

    CAS  PubMed  Google Scholar 

  35. Quesnel C, Piednoir P, Gelly J, Nardelli L, Garnier M, Lecon V, et al. Alveolar fibrocyte percentage is an independent predictor of poor outcome in patients with acute lung injury. Crit Care Med. 2012;40(1):21–8.

    PubMed  Google Scholar 

  36. Gattinoni L, Carlesso E, Valenza F, Chiumello D, Caspani ML. Acute respiratory distress syndrome, the critical care paradigm: what we learned and what we forgot. Curr Opin Crit Care. 2004;10(4):272–8.

    PubMed  Google Scholar 

  37. Mendez JL, Hubmayr RD. New insights into the pathology of acute respiratory failure. Curr Opin Crit Care. 2005;11(1):29–36.

    PubMed  Google Scholar 

  38. Marini JJ, Hotchkiss JR, Broccard AF. Bench-to-bedside review: microvascular and airspace linkage in ventilator-induced lung injury. Crit Care. 2003;7(6):435–44.

    PubMed Central  PubMed  Google Scholar 

  39. Rosenthal C, Caronia C, Quinn C, Lugo N, Sagy M. A comparison among animal models of acute lung injury. Crit Care Med. 1998;26(5):912–6.

    CAS  PubMed  Google Scholar 

  40. Abbas AK, Lichtman AH, Pober JS. Cellular and molecular immunology: cytokines. Philadelphia: Saunders Company; 1994.

    Google Scholar 

  41. Tracey KJ, Lowry SF, Cerami A. Cachetin/TNF-alpha in septic shock and septic adult respiratory distress syndrome. Am Rev Respir Dis. 1988;138(6):1377–9.

    CAS  PubMed  Google Scholar 

  42. Okusawa S, Gelfand JA, Ikejima T, Connolly RJ, Dinarello CA. Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. J Clin Invest. 1988;81(4):1162–72.

    CAS  PubMed Central  PubMed  Google Scholar 

  43. Krieg AM, Love-Homan L, Yi AK, Harty JT. CpG DNA induces sustained IL-12 expression in vivo and resistance to Listeria monocytogenes challenge. J Immunol. 1998;161(5):2428–34.

    CAS  PubMed  Google Scholar 

  44. Brightbill HD, Modlin RL. Toll-like receptors: molecular mechanisms of the mammalian immune response. Immunology. 2000;101(1):1–10.

    CAS  PubMed Central  PubMed  Google Scholar 

  45. Medzhitov R, Janeway Jr CA. Innate immune recognition and control of adaptive immune responses. Semin Immunol. 1998;10(5):351–3.

    CAS  PubMed  Google Scholar 

  46. Medzhitov R, Janeway Jr C. Innate immune recognition: mechanisms and pathways. Immunol Rev. 2000;173:89–97.

    CAS  PubMed  Google Scholar 

  47. Medzhitov R, Janeway Jr C. The Toll receptor family and microbial recognition. Trends Microbiol. 2000;8(10):452–6.

    CAS  PubMed  Google Scholar 

  48. Medzhitov R, Janeway Jr CA. How does the immune system distinguish self from nonself? Semin Immunol. 2000;12(3):185–8. discussion 257–344.

    CAS  PubMed  Google Scholar 

  49. Beutler B, Milsark IW, Cerami AC. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science. 1985;229(4716):869–71.

    CAS  PubMed  Google Scholar 

  50. Beutler B, Cerami A. The biology of cachectin/TNF–a primary mediator of the host response. Annu Rev Immunol. 1989;7:625–55.

    CAS  PubMed  Google Scholar 

  51. Tracey KJ, Fong Y, Hesse DG, Manogue KR, Lee AT, Kuo GC, et al. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature. 1987;330(6149):662–4.

    CAS  PubMed  Google Scholar 

  52. Millar AB, Foley NM, Singer M, Johnson NM, Meager A, Rook GA. Tumour necrosis factor in bronchopulmonary secretions of patients with adult respiratory distress syndrome. Lancet. 1989;2(8665):712–4.

    CAS  PubMed  Google Scholar 

  53. Hyers TM, Tricomi SM, Dettenmeier PA, Fowler AA. Tumor necrosis factor levels in serum and bronchoalveolar lavage fluid of patients with the adult respiratory distress syndrome. Am Rev Respir Dis. 1991;144(2):268–71.

    CAS  PubMed  Google Scholar 

  54. Pugin J, Ricou B, Steinberg KP, Suter PM, Martin TR. Proinflammatory activity in bronchoalveolar lavage fluids from patients with ARDS, a prominent role for interleukin-1. Am J Respir Crit Care Med. 1996;153(6 Pt 1):1850–6.

    CAS  PubMed  Google Scholar 

  55. Dinarello CA. Interleukin-1. Cytokine Growth Factor Rev. 1997;8(4):253–65.

    CAS  PubMed  Google Scholar 

  56. Kunkel SL, Standiford T, Kasahara K, Strieter RM. Interleukin-8 (IL-8): the major neutrophil chemotactic factor in the lung. Exp Lung Res. 1991;17(1):17–23.

    CAS  PubMed  Google Scholar 

  57. Barsness KA, Bensard DD, Partrick DA, Calkins CM, Hendrickson RJ, Banerjee A, et al. IL-1beta induces an exaggerated pro- and anti-inflammatory response in peritoneal macrophages of children compared with adults. Pediatr Surg Int. 2004;20(4):238–42.

    PubMed  Google Scholar 

  58. Oppenheim JJ, Zachariae CO, Mukaida N, Matsushima K. Properties of the novel proinflammatory supergene “intercrine” cytokine family. Annu Rev Immunol. 1991;9:617–48.

    CAS  PubMed  Google Scholar 

  59. Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity. 2000;12(2):121–7.

    CAS  PubMed  Google Scholar 

  60. Greenberger MJ, Strieter RM, Kunkel SL, Danforth JM, Laichalk LL, McGillicuddy DC, et al. Neutralization of macrophage inflammatory protein-2 attenuates neutrophil recruitment and bacterial clearance in murine Klebsiella pneumonia. J Infect Dis. 1996;173(1):159–65.

    CAS  PubMed  Google Scholar 

  61. Mehrad B, Standiford TJ. Role of cytokines in pulmonary antimicrobial host defense. Immunol Res. 1999;20(1):15–27.

    CAS  PubMed  Google Scholar 

  62. Standiford TJ, Strieter RM, Greenberger MJ, Kunkel SL. Expression and regulation of chemokines in acute bacterial pneumonia. Biol Signals. 1996;5(4):203–8.

    CAS  PubMed  Google Scholar 

  63. Mehrad B, Strieter RM, Moore TA, Tsai WC, Lira SA, Standiford TJ. CXC chemokine receptor-2 ligands are necessary components of neutrophil-mediated host defense in invasive pulmonary aspergillosis. J Immunol. 1999;163(11):6086–94.

    CAS  PubMed  Google Scholar 

  64. Tsai WC, Strieter RM, Mehrad B, Newstead MW, Zeng X, Standiford TJ. CXC chemokine receptor CXCR2 is essential for protective innate host response in murine Pseudomonas aeruginosa pneumonia. Infect Immun. 2000;68(7):4289–96.

    CAS  PubMed Central  PubMed  Google Scholar 

  65. Miller EJ, Cohen AB, Nagao S, Griffith D, Maunder RJ, Martin TR, et al. Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am Rev Respir Dis. 1992;146(2):427–32.

    CAS  PubMed  Google Scholar 

  66. Belperio JA, Keane MP, Burdick MD, Londhe V, Xue YY, Li K, et al. Critical role for CXCR2 and CXCR2 ligands during the pathogenesis of ventilator-induced lung injury. J Clin Invest. 2002;110(11):1703–16.

    CAS  PubMed Central  PubMed  Google Scholar 

  67. Speyer CL, Gao H, Rancilio NJ, Neff TA, Huffnagle GB, Sarma JV, et al. Novel chemokine responsiveness and mobilization of neutrophils during sepsis. Am J Pathol. 2004;165(6):2187–96.

    CAS  PubMed Central  PubMed  Google Scholar 

  68. Guo RF, Riedemann NC, Ward PA. Role of C5a-C5aR interaction in sepsis. Shock. 2004;21(1):1–7.

    PubMed  Google Scholar 

  69. Kunkel SL, Strieter RM. Cytokine networking in lung inflammation. Hosp Pract (Off Ed). 1990 Oct 15;25(10):63–6, 9, 73–6.

    Google Scholar 

  70. Arai KI, Lee F, Miyajima A, Miyatake S, Arai N, Yokota T. Cytokines: coordinators of immune and inflammatory responses. Annu Rev Biochem. 1990;59:783–836.

    CAS  PubMed  Google Scholar 

  71. Shanley TP, Warner RL, Ward PA. The role of cytokines and adhesion molecules in the development of inflammatory injury. Mol Med Today. 1995;1(1):40–5.

    CAS  PubMed  Google Scholar 

  72. Shanley TP, Schmal H, Friedl HP, Jones ML, Ward PA. Role of macrophage inflammatory protein-1 alpha (MIP-1 alpha) in acute lung injury in rats. J Immunol. 1995;154(9):4793–802.

    CAS  PubMed  Google Scholar 

  73. Hogg JC, Doerschuk CM. Leukocyte traffic in the lung. Annu Rev Physiol. 1995;57:97–114.

    CAS  PubMed  Google Scholar 

  74. Donnelly SC, Haslett C, Dransfield I, Robertson CE, Carter DC, Ross JA, et al. Role of selectins in development of adult respiratory distress syndrome. Lancet. 1994;344(8917):215–9.

    CAS  PubMed  Google Scholar 

  75. Zimmerman GA, Prescott SM, McIntyre TM. Endothelial cell interactions with granulocytes: tethering and signaling molecules. Immunol Today. 1992;13(3):93–100.

    CAS  PubMed  Google Scholar 

  76. Albelda SM, Smith CW, Ward PA. Adhesion molecules and inflammatory injury. Faseb J. 1994;8(8):504–12.

    CAS  PubMed  Google Scholar 

  77. Lukacs NW, Ward PA. Inflammatory mediators, cytokines, and adhesion molecules in pulmonary inflammation and injury. Adv Immunol. 1996;62:257–304.

    CAS  PubMed  Google Scholar 

  78. Ford-Hutchinson AW, Bray MA, Doig MV, Shipley ME, Smith MJ. Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature. 1980;286(5770):264–5.

    CAS  PubMed  Google Scholar 

  79. Grutz G. New insights into the molecular mechanism of interleukin-10-mediated immunosuppression. J Leukoc Biol. 2005;77(1):3–15.

    PubMed  Google Scholar 

  80. Shanley TP, Schmal H, Friedl HP, Jones ML, Ward PA. Regulatory effects of intrinsic IL-10 in IgG immune complex-induced lung injury. J Immunol. 1995;154(7):3454–60.

    CAS  PubMed  Google Scholar 

  81. Rennick DM, Fort MM, Davidson NJ. Studies with IL-10−/− mice: an overview. J Leukoc Biol. 1997;61(4):389–96.

    CAS  PubMed  Google Scholar 

  82. Donnelly SC, Strieter RM, Reid PT, Kunkel SL, Burdick MD, Armstrong I, et al. The association between mortality rates and decreased concentrations of interleukin-10 and interleukin-1 receptor antagonist in the lung fluids of patients with the adult respiratory distress syndrome. Ann Intern Med. 1996;125(3):191–6.

    CAS  PubMed  Google Scholar 

  83. Bone RC. Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med. 1996;24(7):1125–8.

    CAS  PubMed  Google Scholar 

  84. Bone RC. Why sepsis trials fail. JAMA. 1996;276(7):565–6.

    CAS  PubMed  Google Scholar 

  85. Zeni F, Freeman B, Natanson C. Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment. Crit Care Med. 1997;25(7):1095–100.

    CAS  PubMed  Google Scholar 

  86. Angus DC, Fink MPE. Cellular and molecular biology for intensivists: a primer. Crit Care Med. 2005;33(12):S399–560.

    PubMed  Google Scholar 

  87. Ambrosino N. Noninvasive mechanical ventilation in acute respiratory failure. Monaldi Arch Chest Dis. 1996;51(6):514–8.

    CAS  PubMed  Google Scholar 

  88. Abou-Shala N, Meduri U. Noninvasive mechanical ventilation in patients with acute respiratory failure. Crit Care Med. 1996;24(4):705–15.

    CAS  PubMed  Google Scholar 

  89. Wysocki M, Tric L, Wolff MA, Millet H, Herman B. Noninvasive pressure support ventilation in patients with acute respiratory failure. A randomized comparison with conventional therapy. Chest. 1995;107(3):761–8.

    CAS  PubMed  Google Scholar 

  90. Rocker GM, Mackenzie MG, Williams B, Logan PM. Noninvasive positive pressure ventilation: successful outcome in patients with acute lung injury/ARDS. Chest. 1999;115(1):173–7.

    CAS  PubMed  Google Scholar 

  91. Patrick W, Webster K, Ludwig L, Roberts D, Wiebe P, Younes M. Noninvasive positive-pressure ventilation in acute respiratory distress without prior chronic respiratory failure. Am J Respir Crit Care Med. 1996;153(3):1005–11.

    CAS  PubMed  Google Scholar 

  92. Meade MO, Cook DJ, Guyatt GH, Slutsky AS, Arabi YM, Cooper DJ, et al. Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA. 2008;299(6):637–45.

    CAS  PubMed  Google Scholar 

  93. Mercat A, Richard JC, Vielle B, Jaber S, Osman D, Diehl JL, et al. Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA. 2008;299(6):646–55.

    CAS  PubMed  Google Scholar 

  94. Brower RG, Lanken PN, MacIntyre N, Matthay MA, Morris A, Ancukiewicz M, et al. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med. 2004;351(4):327–36.

    PubMed  Google Scholar 

  95. Caironi P, Cressoni M, Chiumello D, Ranieri M, Quintel M, Russo SG, et al. Lung opening and closing during ventilation of acute respiratory distress syndrome. Am J Respir Crit Care Med. 2010;181(6):578–86.

    PubMed  Google Scholar 

  96. Brochard L. New goals for positive end-expiratory pressure in acute respiratory distress syndrome: a paradigm shift or the end of an area of uncertainty? Am J Respir Crit Care Med. 2010;181(6):528–30.

    PubMed  Google Scholar 

  97. Gattinoni L, Caironi P, Cressoni M, Chiumello D, Ranieri VM, Quintel M, et al. Lung recruitment in patients with the acute respiratory distress syndrome. N Engl J Med. 2006;354(17):1775–86.

    CAS  PubMed  Google Scholar 

  98. Barbas CS, de Matos GF, Okamoto V, Borges JB, Amato MB, de Carvalho CR. Lung recruitment maneuvers in acute respiratory distress syndrome. Respir Care Clin N Am. 2003;9(4):401–18, vii.

    Google Scholar 

  99. Talmor D, Sarge T, Malhotra A, O’Donnell CR, Ritz R, Lisbon A, et al. Mechanical ventilation guided by esophageal pressure in acute lung injury. N Engl J Med. 2008;359(20):2095–104.

    CAS  PubMed Central  PubMed  Google Scholar 

  100. Boriosi JP, Sapru A, Hanson JH, Asselin J, Gildengorin G, Newman V, et al. Efficacy and safety of lung recruitment in pediatric patients with acute lung injury. Pediatr Crit Care Med. 2011;12(4):431–6.

    PubMed  Google Scholar 

  101. Boriosi JP, Cohen RA, Summers E, Sapru A, Hanson JH, Gildengorin G, et al. Lung aeration changes after lung recruitment in children with acute lung injury: a feasibility study. Pediatr Pulmonol. 2012;47(8):771–9.

    PubMed  Google Scholar 

  102. Grasso S, Stripoli T, De Michele M, Bruno F, Moschetta M, Angelelli G, et al. ARDSnet ventilatory protocol and alveolar hyperinflation: role of positive end-expiratory pressure. Am J Respir Crit Care Med. 2007;176(8):761–7.

    PubMed  Google Scholar 

  103. Puybasset L, Gusman P, Muller JC, Cluzel P, Coriat P, Rouby JJ. Regional distribution of gas and tissue in acute respiratory distress syndrome. III. Consequences for the effects of positive end-expiratory pressure. CT Scan ARDS Study Group. Adult Respiratory Distress Syndrome. Intensive Care Med. 2000;26(9):1215–27.

    CAS  PubMed  Google Scholar 

  104. Feihl F, Broccard AF. Interactions between respiration and systemic hemodynamics. Part I: basic concepts. Intensive Care Med. 2009;35(1):45–54.

    PubMed  Google Scholar 

  105. Feihl F, Broccard AF. Interactions between respiration and systemic hemodynamics. Part II: practical implications in critical care. Intensive Care Med. 2009;35(2):198–205.

    PubMed  Google Scholar 

  106. Walley KR. Use of central venous oxygen saturation to guide therapy. Am J Respir Crit Care Med. 2011;184(5):514–20.

    PubMed  Google Scholar 

  107. Wheeler AP, Bernard GR. Acute lung injury and the acute respiratory distress syndrome: a clinical review. Lancet. 2007;369(9572):1553–64.

    PubMed  Google Scholar 

  108. Marcy TW, Marini JJ. Inverse ratio ventilation in ARDS. Rationale and implementation. Chest. 1991;100(2):494–504.

    CAS  PubMed  Google Scholar 

  109. Armstrong Jr BW, MacIntyre NR. Pressure-controlled, inverse ratio ventilation that avoids air trapping in the adult respiratory distress syndrome. Crit Care Med. 1995;23(2):279–85.

    PubMed  Google Scholar 

  110. Lessard MR, Guerot E, Lorino H, Lemaire F, Brochard L. Effects of pressure-controlled with different I:E ratios versus volume-controlled ventilation on respiratory mechanics, gas exchange, and hemodynamics in patients with adult respiratory distress syndrome. Anesthesiology. 1994;80(5):983–91.

    CAS  PubMed  Google Scholar 

  111. Mercat A, Titiriga M, Anguel N, Richard C, Teboul JL. Inverse ratio ventilation (I/E=2/1) in acute respiratory distress syndrome: a six-hour controlled study. Am J Respir Crit Care Med. 1997;155(5):1637–42.

    CAS  PubMed  Google Scholar 

  112. Krishnan JA, Brower RG. High-frequency ventilation for acute lung injury and ARDS. Chest. 2000;118(3):795–807.

    CAS  PubMed  Google Scholar 

  113. Arnold JH, Hanson JH, Toro-Figuero LO, Gutierrez J, Berens RJ, Anglin DL. Prospective, randomized comparison of high-frequency oscillatory ventilation and conventional mechanical ventilation in pediatric respiratory failure. Crit Care Med. 1994;22(10):1530–9.

    CAS  PubMed  Google Scholar 

  114. Arnold JH, Anas NG, Luckett P, Cheifetz IM, Reyes G, Newth CJ, et al. High-frequency oscillatory ventilation in pediatric respiratory failure: a multicenter experience. Crit Care Med. 2000;28(12):3913–9.

    CAS  PubMed  Google Scholar 

  115. Fedora M, Klimovic M, Seda M, Dominik P, Nekvasil R. Effect of early intervention of high-frequency oscillatory ventilation on the outcome in pediatric acute respiratory distress syndrome. Bratisl Lek Listy. 2000;101(1):8–13.

    CAS  PubMed  Google Scholar 

  116. Fessler HE, Derdak S, Ferguson ND, Hager DN, Kacmarek RM, Thompson BT, et al. A protocol for high-frequency oscillatory ventilation in adults: results from a roundtable discussion. Crit Care Med. 2007;35(7):1649–54.

    PubMed  Google Scholar 

  117. Ip T, Mehta S. The role of high-frequency oscillatory ventilation in the treatment of acute respiratory failure in adults. Curr Opin Crit Care. 2012;18(1):70–9.

    PubMed  Google Scholar 

  118. Chan KP, Stewart TE, Mehta S. High-frequency oscillatory ventilation for adult patients with ARDS. Chest. 2007;131(6):1907–16.

    PubMed  Google Scholar 

  119. Wispe JR, Roberts RJ. Molecular basis of pulmonary oxygen toxicity. Clin Perinatol. 1987;14(3):651–66.

    CAS  PubMed  Google Scholar 

  120. Abdelsalam M, Cheifetz IM. Goal-directed therapy for severely hypoxic patients with acute respiratory distress syndrome: permissive hypoxemia. Respir Care. 2010;55(11):1483–90.

    PubMed  Google Scholar 

  121. dos Santos CC, Slutsky AS. Mechanotransduction, ventilator-induced lung injury and multiple organ dysfunction syndrome. Intensive Care Med. 2000;26(5):638–42.

    PubMed  Google Scholar 

  122. Lee WL, Slutsky AS. Ventilator-induced lung injury and recommendations for mechanical ventilation of patients with ARDS. Semin Respir Crit Care Med. 2001;22(3):269–80.

    CAS  PubMed  Google Scholar 

  123. Lin CY, Zhang H, Cheng KC, Slutsky AS. Mechanical ventilation may increase susceptibility to the development of bacteremia. Crit Care Med. 2003;31(5):1429–34.

    PubMed  Google Scholar 

  124. Imai Y, Parodo J, Kajikawa O, de Perrot M, Fischer S, Edwards V, et al. Injurious mechanical ventilation and end-organ epithelial cell apoptosis and organ dysfunction in an experimental model of acute respiratory distress syndrome. JAMA. 2003;289(16):2104–12.

    PubMed  Google Scholar 

  125. Plotz FB, Vreugdenhil HA, Slutsky AS, Zijlstra J, Heijnen CJ, van Vught H. Mechanical ventilation alters the immune response in children without lung pathology. Intensive Care Med. 2002;28(4):486–92.

    PubMed  Google Scholar 

  126. Slutsky AS. The acute respiratory distress syndrome, mechanical ventilation, and the prone position. N Engl J Med. 2001;345(8):610–2.

    CAS  PubMed  Google Scholar 

  127. Veldhuizen RA, Slutsky AS, Joseph M, McCaig L. Effects of mechanical ventilation of isolated mouse lungs on surfactant and inflammatory cytokines. Eur Respir J. 2001;17(3):488–94.

    CAS  PubMed  Google Scholar 

  128. Ranieri VM, Giunta F, Suter PM, Slutsky AS. Mechanical ventilation as a mediator of multisystem organ failure in acute respiratory distress syndrome. JAMA. 2000;284(1):43–4.

    CAS  PubMed  Google Scholar 

  129. Slutsky AS. Lung injury caused by mechanical ventilation. Chest. 1999;116(1 Suppl):9S–15.

    CAS  PubMed  Google Scholar 

  130. Ranieri VM, Suter PM, Tortorella C, De Tullio R, Dayer JM, Brienza A, et al. Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial. JAMA. 1999;282(1):54–61.

    CAS  PubMed  Google Scholar 

  131. Mehta S, Slutsky AS. Mechanical ventilation in acute respiratory distress syndrome: evolving concepts. Monaldi Arch Chest Dis. 1998;53(6):647–53.

    CAS  PubMed  Google Scholar 

  132. Slutsky AS, Tremblay LN. Multiple system organ failure. Is mechanical ventilation a contributing factor? Am J Respir Crit Care Med. 1998;157(6 Pt 1):1721–5.

    CAS  PubMed  Google Scholar 

  133. Slutsky AS. Mechanical ventilation. American College of Chest Physicians’ Consensus Conference. Chest. 1993;104(6):1833–59.

    CAS  PubMed  Google Scholar 

  134. Kolobow T, Moretti MP, Fumagalli R, Mascheroni D, Prato P, Chen V, et al. Severe impairment in lung function induced by high peak airway pressure during mechanical ventilation. An experimental study. Am Rev Respir Dis. 1987;135(2):312–5.

    CAS  PubMed  Google Scholar 

  135. Chiumello D, Pristine G, Slutsky AS. Mechanical ventilation affects local and systemic cytokines in an animal model of acute respiratory distress syndrome. Am J Respir Crit Care Med. 1999;160(1):109–16.

    CAS  PubMed  Google Scholar 

  136. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med. 2000 May 4;342(18):1301–8.

    Google Scholar 

  137. Brochard L, Roudot-Thoraval F, Roupie E, Delclaux C, Chastre J, Fernandez-Mondejar E, et al. Tidal volume reduction for prevention of ventilator-induced lung injury in acute respiratory distress syndrome. The Multicenter Trail Group on Tidal Volume reduction in ARDS. Am J Respir Crit Care Med. 1998;158(6):1831–8.

    CAS  PubMed  Google Scholar 

  138. Brower RG, Shanholtz CB, Fessler HE, Shade DM, White Jr P, Wiener CM, et al. Prospective, randomized, controlled clinical trial comparing traditional versus reduced tidal volume ventilation in acute respiratory distress syndrome patients. Crit Care Med. 1999;27(8):1492–8.

    CAS  PubMed  Google Scholar 

  139. Hickling KG, Henderson SJ, Jackson R. Low mortality associated with low volume pressure limited ventilation with permissive hypercapnia in severe adult respiratory distress syndrome. Intensive Care Med. 1990;16(6):372–7.

    CAS  PubMed  Google Scholar 

  140. Ni Chonghaile M, Higgins B, Laffey JG. Permissive hypercapnia: role in protective lung ventilatory strategies. Curr Opin Crit Care. 2005;11(1):56–62.

    PubMed  Google Scholar 

  141. Laffey JG, O’Croinin D, McLoughlin P, Kavanagh BP. Permissive hypercapnia–role in protective lung ventilatory strategies. Intensive Care Med. 2004;30(3):347–56.

    PubMed  Google Scholar 

  142. Sevransky JE, Levy MM, Marini JJ. Mechanical ventilation in sepsis-induced acute lung injury/acute respiratory distress syndrome: an evidence-based review. Crit Care Med. 2004;32(11 Suppl):S548–53.

    PubMed  Google Scholar 

  143. Broccard AF, Hotchkiss JR, Vannay C, Markert M, Sauty A, Feihl F, et al. Protective effects of hypercapnic acidosis on ventilator-induced lung injury. Am J Respir Crit Care Med. 2001;164(5):802–6.

    CAS  PubMed  Google Scholar 

  144. Sinclair SE, Kregenow DA, Lamm WJ, Starr IR, Chi EY, Hlastala MP. Hypercapnic acidosis is protective in an in vivo model of ventilator-induced lung injury. Am J Respir Crit Care Med. 2002;166(3):403–8.

    PubMed  Google Scholar 

  145. Laffey JG, Tanaka M, Engelberts D, Luo X, Yuan S, Tanswell AK, et al. Therapeutic hypercapnia reduces pulmonary and systemic injury following in vivo lung reperfusion. Am J Respir Crit Care Med. 2000;162(6):2287–94.

    CAS  PubMed  Google Scholar 

  146. O’Croinin D, Ni Chonghaile M, Higgins B, Laffey JG. Bench-to-bedside review: permissive hypercapnia. Crit Care. 2005;9(1):51–9.

    PubMed  Google Scholar 

  147. Feihl F, Perret C. Permissive hypercapnia. How permissive should we be? Am J Respir Crit Care Med. 1994;150(6 Pt 1):1722–37.

    CAS  PubMed  Google Scholar 

  148. Adrogue HJ, Madias NE. Management of life-threatening acid-base disorders. First of two parts. N Engl J Med. 1998;338(1):26–34.

    CAS  PubMed  Google Scholar 

  149. Kallet RH, Jasmer RM, Luce JM, Lin LH, Marks JD. The treatment of acidosis in acute lung injury with tris-hydroxymethyl aminomethane (THAM). Am J Respir Crit Care Med. 2000;161(4 Pt 1):1149–53.

    CAS  PubMed  Google Scholar 

  150. Pappert D, Rossaint R, Slama K, Gruning T, Falke KJ. Influence of positioning on ventilation-perfusion relationships in severe adult respiratory distress syndrome. Chest. 1994;106(5):1511–6.

    CAS  PubMed  Google Scholar 

  151. Curley MA, Thompson JE, Arnold JH. The effects of early and repeated prone positioning in pediatric patients with acute lung injury. Chest. 2000;118(1):156–63.

    CAS  PubMed  Google Scholar 

  152. Casado-Flores J, Martinez de Azagra A, Ruiz-Lopez MJ, Ruiz M, Serrano A. Pediatric ARDS: effect of supine-prone postural changes on oxygenation. Intensive Care Med. 2002;28(12):1792–6.

    PubMed  Google Scholar 

  153. Curley MA, Hibberd PL, Fineman LD, Wypij D, Shih MC, Thompson JE, et al. Effect of prone positioning on clinical outcomes in children with acute lung injury: a randomized controlled trial. JAMA. 2005;294(2):229–37.

    CAS  PubMed Central  PubMed  Google Scholar 

  154. Gattinoni L, Tognoni G, Pesenti A, Taccone P, Mascheroni D, Labarta V, et al. Effect of prone positioning on the survival of patients with acute respiratory failure. N Engl J Med. 2001;345(8):568–73.

    CAS  PubMed  Google Scholar 

  155. Hudson LD. Fluid management strategy in acute lung injury. Am Rev Respir Dis. 1992;145(5):988–9.

    CAS  PubMed  Google Scholar 

  156. Hyers TM. ARDS: the therapeutic dilemma. Chest. 1990;97(5):1025.

    CAS  PubMed  Google Scholar 

  157. Schuller D, Mitchell JP, Calandrino FS, Schuster DP. Fluid balance during pulmonary edema Is fluid gain a marker or a cause of poor outcome? Chest. 1991;100(4):1068–75.

    CAS  PubMed  Google Scholar 

  158. Sznajder JI. Alveolar edema must be cleared for the acute respiratory distress syndrome patient to survive. Am J Respir Crit Care Med. 2001;163(6):1293–4.

    CAS  PubMed  Google Scholar 

  159. Ware LB, Matthay MA. Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med. 2001;163(6):1376–83.

    CAS  PubMed  Google Scholar 

  160. Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, deBoisblanc B, et al. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med. 2006;354(24):2564–75.

    CAS  PubMed  Google Scholar 

  161. Clermont G, Kong L, Weissfeld LA, Lave JR, Rubenfeld GD, Roberts MS, et al. The effect of pulmonary artery catheter use on costs and long-term outcomes of acute lung injury. PLoS One. 2011;6(7):e22512.

    CAS  PubMed Central  PubMed  Google Scholar 

  162. Rocco PR, Souza AB, Faffe DS, Passaro CP, Santos FB, Negri EM, et al. Effect of corticosteroid on lung parenchyma remodeling at an early phase of acute lung injury. Am J Respir Crit Care Med. 2003;168(6):677–84.

    PubMed  Google Scholar 

  163. Meduri GU, Headley AS, Golden E, Carson SJ, Umberger RA, Kelso T, et al. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA. 1998;280(2):159–65.

    CAS  PubMed  Google Scholar 

  164. Thompson BT. Glucocorticoids and acute lung injury. Crit Care Med. 2003;31(4 Suppl):S253–7.

    CAS  PubMed  Google Scholar 

  165. Weigelt JA, Norcross JF, Borman KR, Snyder 3rd WH. Early steroid therapy for respiratory failure. Arch Surg. 1985;120(5):536–40.

    CAS  PubMed  Google Scholar 

  166. Bone RC, Fisher Jr CJ, Clemmer TP, Slotman GJ, Metz CA. Early methylprednisolone treatment for septic syndrome and the adult respiratory distress syndrome. Chest. 1987;92(6):1032–6.

    CAS  PubMed  Google Scholar 

  167. Bernard GR, Luce JM, Sprung CL, Rinaldo JE, Tate RM, Sibbald WJ, et al. High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med. 1987;317(25):1565–70.

    CAS  PubMed  Google Scholar 

  168. Steinberg KP, Hudson LD, Goodman RB, Hough CL, Lanken PN, Hyzy R, et al. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med. 2006;354(16):1671–84.

    CAS  PubMed  Google Scholar 

  169. Meduri GU, Golden E, Freire AX, Taylor E, Zaman M, Carson SJ, et al. Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest. 2007;131(4):954–63.

    CAS  PubMed  Google Scholar 

  170. Confalonieri M, Urbino R, Potena A, Piattella M, Parigi P, Puccio G, et al. Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med. 2005;171(3):242–8.

    PubMed  Google Scholar 

  171. Derde S, Hermans G, Derese I, Guiza F, Hedstrom Y, Wouters PJ, et al. Muscle atrophy and preferential loss of myosin in prolonged critically ill patients. Crit Care Med. 2012;40(1):79–89.

    PubMed  Google Scholar 

  172. Griffiths MJ, Evans TW. Inhaled nitric oxide therapy in adults. N Engl J Med. 2005;353(25):2683–95.

    CAS  PubMed  Google Scholar 

  173. Payen DM. Inhaled nitric oxide and acute lung injury. Clin Chest Med. 2000;21 3:519–29, ix.

    Google Scholar 

  174. Puybasset L, Rouby JJ. Pulmonary uptake and modes of administration of inhaled nitric oxide in mechanically-ventilated patients. Crit Care. 1998;2(1):9–17.

    PubMed Central  PubMed  Google Scholar 

  175. Rossaint R, Falke KJ, Lopez F, Slama K, Pison U, Zapol WM. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med. 1993;328(6):399–405.

    CAS  PubMed  Google Scholar 

  176. Adnot S, Raffestin B, Eddahibi S. NO in the lung. Respir Physiol. 1995;101(2):109–20.

    CAS  PubMed  Google Scholar 

  177. Pison U, Lopez FA, Heidelmeyer CF, Rossaint R, Falke KJ. Inhaled nitric oxide reverses hypoxic pulmonary vasoconstriction without impairing gas exchange. J Appl Physiol. 1993;74(3):1287–92.

    CAS  PubMed  Google Scholar 

  178. Creagh-Brown BC, Griffiths MJ, Evans TW. Bench-to-bedside review: inhaled nitric oxide therapy in adults. Crit Care. 2009;13(3):221.

    PubMed Central  PubMed  Google Scholar 

  179. Dellinger RP, Zimmerman JL, Taylor RW, Straube RC, Hauser DL, Criner GJ, et al. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study Group. Crit Care Med. 1998;26(1):15–23.

    CAS  PubMed  Google Scholar 

  180. Troncy E, Collet JP, Shapiro S, Guimond JG, Blair L, Ducruet T, et al. Inhaled nitric oxide in acute respiratory distress syndrome: a pilot randomized controlled study. Am J Respir Crit Care Med. 1998;157(5 Pt 1):1483–8.

    CAS  PubMed  Google Scholar 

  181. Michael JR, Barton RG, Saffle JR, Mone M, Markewitz BA, Hillier K, et al. Inhaled nitric oxide versus conventional therapy: effect on oxygenation in ARDS. Am J Respir Crit Care Med. 1998;157(5 Pt 1):1372–80.

    CAS  PubMed  Google Scholar 

  182. Taylor RW, Zimmerman JL, Dellinger RP, Straube RC, Criner GJ, Davis Jr K, et al. Low-dose inhaled nitric oxide in patients with acute lung injury: a randomized controlled trial. JAMA. 2004;291(13):1603–9.

    CAS  PubMed  Google Scholar 

  183. Lundin S, Mang H, Smithies M, Stenqvist O, Frostell C. Inhalation of nitric oxide in acute lung injury: results of a European multicentre study. The European Study Group of inhaled nitric oxide. Intensive Care Med. 1999;25(9):911–9.

    CAS  PubMed  Google Scholar 

  184. Adhikari NK, Burns KE, Friedrich JO, Granton JT, Cook DJ, Meade MO. Effect of nitric oxide on oxygenation and mortality in acute lung injury: systematic review and meta-analysis. BMJ. 2007;334(7597):779.

    PubMed Central  PubMed  Google Scholar 

  185. Abman SH, Griebel JL, Parker DK, Schmidt JM, Swanton D, Kinsella JP. Acute effects of inhaled nitric oxide in children with severe hypoxemic respiratory failure. J Pediatr. 1994;124(6):881–8.

    CAS  PubMed  Google Scholar 

  186. Dobyns EL, Cornfield DN, Anas NG, Fortenberry JD, Tasker RC, Lynch A, et al. Multicenter randomized controlled trial of the effects of inhaled nitric oxide therapy on gas exchange in children with acute hypoxemic respiratory failure. J Pediatr. 1999;134(4):406–12.

    CAS  PubMed  Google Scholar 

  187. Dobyns EL, Anas NG, Fortenberry JD, Deshpande J, Cornfield DN, Tasker RC, et al. Interactive effects of high-frequency oscillatory ventilation and inhaled nitric oxide in acute hypoxemic respiratory failure in pediatrics. Crit Care Med. 2002;30(11):2425–9.

    CAS  PubMed  Google Scholar 

  188. Warren JB, Higenbottam T. Caution with use of inhaled nitric oxide. Lancet. 1996;348(9028):629–30.

    CAS  PubMed  Google Scholar 

  189. Quinn AC, Petros AJ, Vallance P. Nitric oxide: an endogenous gas. Br J Anaesth. 1995;74(4):443–51.

    CAS  PubMed  Google Scholar 

  190. Zabrocki LA, Brogan TV, Statler KD, Poss WB, Rollins MD, Bratton SL. Extracorporeal membrane oxygenation for pediatric respiratory failure: survival and predictors of mortality. Crit Care Med. 2011;39(2):364–70.

    PubMed  Google Scholar 

  191. Moler FW, Palmisano JM, Green TP, Custer JR. Predictors of outcome of severe respiratory syncytial virus-associated respiratory failure treated with extracorporeal membrane oxygenation. J Pediatr. 1993;123(1):46–52.

    CAS  PubMed  Google Scholar 

  192. Green TP, Moler FW, Goodman DM. Probability of survival after prolonged extracorporeal membrane oxygenation in pediatric patients with acute respiratory failure. Extracorporeal Life Support Organization. Crit Care Med. 1995;23(6):1132–9.

    CAS  PubMed  Google Scholar 

  193. Pranikoff T, Hirschl RB, Steimle CN, Anderson 3rd HL, Bartlett RH. Mortality is directly related to the duration of mechanical ventilation before the initiation of extracorporeal life support for severe respiratory failure. Crit Care Med. 1997;25(1):28–32.

    CAS  PubMed  Google Scholar 

  194. Trachsel D, McCrindle BW, Nakagawa S, Bohn D. Oxygenation index predicts outcome in children with acute hypoxemic respiratory failure. Am J Respir Crit Care Med. 2005;172(2):206–11.

    PubMed  Google Scholar 

  195. Hemmila MR, Rowe SA, Boules TN, Miskulin J, McGillicuddy JW, Schuerer DJ, et al. Extracorporeal life support for severe acute respiratory distress syndrome in adults. Ann Surg. 2004;240(4):595–605; discussion −7.

    Google Scholar 

  196. Rollins MD, Hubbard A, Zabrocki L, Barnhart DC, Bratton SL. Extracorporeal membrane oxygenation cannulation trends for pediatric respiratory failure and central nervous system injury. J Pediatr Surg. 2012;47(1):68–75.

    PubMed  Google Scholar 

  197. Zahraa JN, Moler FW, Annich GM, Maxvold NJ, Bartlett RH, Custer JR. Venovenous versus venoarterial extracorporeal life support for pediatric respiratory failure: are there differences in survival and acute complications? Crit Care Med. 2000;28(2):521–5.

    CAS  PubMed  Google Scholar 

  198. Peek GJ, Mugford M, Tiruvoipati R, Wilson A, Allen E, Thalanany MM, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet. 2009;374(9698):1351–63.

    PubMed  Google Scholar 

  199. Bogdan C, Vodovotz Y, Nathan C. Macrophage deactivation by interleukin 10. J Exp Med. 1991;174(6):1549–55.

    CAS  PubMed  Google Scholar 

  200. Bogdan C, Paik J, Vodovotz Y, Nathan C. Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-beta and interleukin-10. J Biol Chem. 1992;267(32):23301–8.

    CAS  PubMed  Google Scholar 

  201. DeVries A, Semchuk WM, Betcher JG. Ketoconazole in the prevention of acute respiratory distress syndrome. Pharmacotherapy. 1998;18(3):581–7.

    CAS  PubMed  Google Scholar 

  202. Williams JG, Maier RV. Ketoconazole inhibits alveolar macrophage production of inflammatory mediators involved in acute lung injury (adult respiratory distress syndrome). Surgery. 1992;112(2):270–7.

    CAS  PubMed  Google Scholar 

  203. Randomized, placebo-controlled trial of lisofylline for early treatment of acute lung injury and acute respiratory distress syndrome. Crit Care Med. 2002;30 1:1–6.

    Google Scholar 

  204. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med. 1991;174(5):1209–20.

    PubMed  Google Scholar 

  205. Krakauer T. IL-10 inhibits the adhesion of leukocytic cells to IL-1-activated human endothelial cells. Immunol Lett. 1995;45(1–2):61–5.

    CAS  PubMed  Google Scholar 

  206. Wang P, Wu P, Siegel MI, Egan RW, Billah MM. Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J Biol Chem. 1995;270(16):9558–63.

    CAS  PubMed  Google Scholar 

  207. Lentsch AB, Shanley TP, Sarma V, Ward PA. In vivo suppression of NF-kappa B and preservation of I kappa B alpha by interleukin-10 and interleukin-13. J Clin Invest. 1997;100(10):2443–8.

    CAS  PubMed Central  PubMed  Google Scholar 

  208. Cassatella MA, Meda L, Gasperini S, Calzetti F, Bonora S. Interleukin 10 (IL-10) upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNA degradation. J Exp Med. 1994;179(5):1695–9.

    CAS  PubMed  Google Scholar 

  209. Brown CY, Lagnado CA, Vadas MA, Goodall GJ. Differential regulation of the stability of cytokine mRNAs in lipopolysaccharide-activated blood monocytes in response to interleukin-10. J Biol Chem. 1996;271(33):20108–12.

    CAS  PubMed  Google Scholar 

  210. Fisher Jr CJ, Agosti JM, Opal SM, Lowry SF, Balk RA, Sadoff JC, et al. Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein The Soluble TNF Receptor Sepsis Study Group. N Engl J Med. 1996;334(26):1697–702.

    CAS  PubMed  Google Scholar 

  211. Lemeshow S, Teres D, Moseley S. Statistical issues in clinical sepsis trials. Fink MPE, editor. Baltimore: Williams and Wilkins; 1996.

    Google Scholar 

  212. Yanik GA, Ho VT, Levine JE, White ES, Braun T, Antin JH, et al. The impact of soluble tumor necrosis factor receptor etanercept on the treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation. Blood. 2008;112(8):3073–81.

    CAS  PubMed Central  PubMed  Google Scholar 

  213. Berthiaume Y, Folkesson HG, Matthay MA. Lung edema clearance: 20 years of progress: invited review: alveolar edema fluid clearance in the injured lung. J Appl Physiol. 2002;93(6):2207–13.

    PubMed  Google Scholar 

  214. Matthay MA, Clerici C, Saumon G. Invited review: active fluid clearance from the distal air spaces of the lung. J Appl Physiol. 2002;93(4):1533–41.

    CAS  PubMed  Google Scholar 

  215. Modelska K, Matthay MA, Brown LA, Deutch E, Lu LN, Pittet JF. Inhibition of beta-adrenergic-dependent alveolar epithelial clearance by oxidant mechanisms after hemorrhagic shock. Am J Physiol. 1999;276(5 Pt 1):L844–57.

    CAS  PubMed  Google Scholar 

  216. Pittet JF, Wiener-Kronish JP, McElroy MC, Folkesson HG, Matthay MA. Stimulation of lung epithelial liquid clearance by endogenous release of catecholamines in septic shock in anesthetized rats. J Clin Invest. 1994;94(2):663–71.

    CAS  PubMed Central  PubMed  Google Scholar 

  217. Campbell AR, Folkesson HG, Berthiaume Y, Gutkowska J, Suzuki S, Matthay MA. Alveolar epithelial fluid clearance persists in the presence of moderate left atrial hypertension in sheep. J Appl Physiol. 1999;86(1):139–51.

    CAS  PubMed  Google Scholar 

  218. Carter EP, Duvick SE, Wendt CH, Dunitz J, Nici L, Wangensteen OD, et al. Hyperoxia increases active alveolar Na+resorption in vivo and type II cell Na. K-ATPase in vitro. Chest. 1994;105(3 Suppl):75S–8.

    CAS  PubMed  Google Scholar 

  219. Minakata Y, Suzuki S, Grygorczyk C, Dagenais A, Berthiaume Y. Impact of beta-adrenergic agonist on Na+channel and Na+−K+−ATPase expression in alveolar type II cells. Am J Physiol. 1998;275(2 Pt 1):L414–22.

    CAS  PubMed  Google Scholar 

  220. Folkesson HG, Norlin A, Wang Y, Abedinpour P, Matthay MA. Dexamethasone and thyroid hormone pretreatment upregulate alveolar epithelial fluid clearance in adult rats. J Appl Physiol. 2000;88(2):416–24.

    CAS  PubMed  Google Scholar 

  221. Perkins GD, McAuley DF, Thickett DR, Gao F. The beta-agonist lung injury trial (BALTI): a randomized placebo-controlled clinical trial. Am J Respir Crit Care Med. 2006;173(3):281–7.

    CAS  PubMed  Google Scholar 

  222. Perkins GD, McAuley DF. Pro: beta-agonists in acute lung injury–the end of the story? Am J Respir Crit Care Med. 2011;184(5):503–4.

    PubMed  Google Scholar 

  223. Papazian L. Con: beta2-adrenergic agonists in ALI/ARDS–not recommended or potentially harmful? Am J Respir Crit Care Med. 2011;184(5):504–6.

    PubMed  Google Scholar 

  224. Thompson BT. 21) beta-agonists for ARDS: the dark side of adrenergic stimulation? Lancet. 2012;379(9812):196–8.

    PubMed  Google Scholar 

  225. Matthay MA, Brower RG, Carson S, Douglas IS, Eisner M, Hite D, et al. Randomized, placebo-controlled clinical trial of an aerosolized beta-agonist for treatment of acute lung injury. Am J Respir Crit Care Med. 2011;184(5):561–8.

    CAS  PubMed  Google Scholar 

  226. Briot R, Bayat S, Anglade D, Martiel JL, Grimbert F. Increased cardiac index due to terbutaline treatment aggravates capillary-alveolar macromolecular leakage in oleic acid lung injury in dogs. Crit Care. 2009;13(5):R166.

    PubMed Central  PubMed  Google Scholar 

  227. Au DH, Curtis JR, Every NR, McDonell MB, Fihn SD. Association between inhaled beta-agonists and the risk of unstable angina and myocardial infarction. Chest. 2002;121(3):846–51.

    CAS  PubMed  Google Scholar 

  228. Millar EA, Connell JM, Thomson NC. The effect of nebulized albuterol on the activity of the renin-angiotensin system in asthma. Chest. 1997;111(1):71–4.

    CAS  PubMed  Google Scholar 

  229. Frank JA, Pittet JF, Lee H, Godzich M, Matthay MA. High tidal volume ventilation induces NOS2 and impairs cAMP- dependent air space fluid clearance. Am J Physiol Lung Cell Mol Physiol. 2003;284(5):L791–8.

    CAS  PubMed  Google Scholar 

  230. Sartori C, Allemann Y, Duplain H, Lepori M, Egli M, Lipp E, et al. Salmeterol for the prevention of high-altitude pulmonary edema. N Engl J Med. 2002;346(21):1631–6.

    CAS  PubMed  Google Scholar 

  231. Licker M, Tschopp JM, Robert J, Frey JG, Diaper J, Ellenberger C. Aerosolized salbutamol accelerates the resolution of pulmonary edema after lung resection. Chest. 2008;133(4):845–52.

    CAS  PubMed  Google Scholar 

  232. Ware LB, Koyama T, Billheimer D, Landeck M, Johnson E, Brady S, et al. Advancing donor management research: design and implementation of a large, randomized, placebo-controlled trial. Ann Intensive Care. 2011;1(1):20.

    PubMed Central  PubMed  Google Scholar 

  233. Viget NB, Guery BP, Ader F, Neviere R, Alfandari S, Creuzy C, et al. Keratinocyte growth factor protects against Pseudomonas aeruginosa-induced lung injury. Am J Physiol Lung Cell Mol Physiol. 2000;279(6):L1199–209.

    CAS  PubMed  Google Scholar 

  234. Stern M, Ulrich K, Robinson C, Copeland J, Griesenbach U, Masse C, et al. Pretreatment with cationic lipid-mediated transfer of the Na+K+−ATPase pump in a mouse model in vivo augments resolution of high permeability pulmonary oedema. Gene Ther. 2000;7(11):960–6.

    CAS  PubMed  Google Scholar 

  235. Kumasaka T, Quinlan WM, Doyle NA, Condon TP, Sligh J, Takei F, et al. Role of the intercellular adhesion molecule-1(ICAM-1) in endotoxin-induced pneumonia evaluated using ICAM-1 antisense oligonucleotides, anti-ICAM-1 monoclonal antibodies, and ICAM-1 mutant mice. J Clin Invest. 1996;97(10):2362–9.

    CAS  PubMed Central  PubMed  Google Scholar 

  236. Doerschuk CM, Quinlan WM, Doyle NA, Bullard DC, Vestweber D, Jones ML, et al. The role of P-selectin and ICAM-1 in acute lung injury as determined using blocking antibodies and mutant mice. J Immunol. 1996;157(10):4609–14.

    CAS  PubMed  Google Scholar 

  237. Ridings PC, Windsor AC, Jutila MA, Blocher CR, Fisher BJ, Sholley MM, et al. A dual-binding antibody to E- and L-selectin attenuates sepsis-induced lung injury. Am J Respir Crit Care Med. 1995;152(1):247–53.

    CAS  PubMed  Google Scholar 

  238. Mulligan MS, Miyasaka M, Tamatani T, Jones ML, Ward PA. Requirements for L-selectin in neutrophil-mediated lung injury in rats. J Immunol. 1994;152(2):832–40.

    CAS  PubMed  Google Scholar 

  239. Mulligan MS, Polley MJ, Bayer RJ, Nunn MF, Paulson JC, Ward PA. Neutrophil-dependent acute lung injury. Requirement for P-selectin (GMP-140). J Clin Invest. 1992;90(4):1600–7.

    CAS  PubMed Central  PubMed  Google Scholar 

  240. Etzioni A, Alon R. Leukocyte adhesion deficiency III: a group of integrin activation defects in hematopoietic lineage cells. Curr Opin Allergy Clin Immunol. 2004;4(6):485–90.

    CAS  PubMed  Google Scholar 

  241. Kinashi T, Aker M, Sokolovsky-Eisenberg M, Grabovsky V, Tanaka C, Shamri R, et al. LAD-III, a leukocyte adhesion deficiency syndrome associated with defective Rap1 activation and impaired stabilization of integrin bonds. Blood. 2004;103(3):1033–6.

    CAS  PubMed  Google Scholar 

  242. Matsumoto T, Yokoi K, Mukaida N, Harada A, Yamashita J, Watanabe Y, et al. Pivotal role of interleukin-8 in the acute respiratory distress syndrome and cerebral reperfusion injury. J Leukoc Biol. 1997;62(5):581–7.

    CAS  PubMed  Google Scholar 

  243. Folkesson HG, Matthay MA, Hebert CA, Broaddus VC. Acid aspiration-induced lung injury in rabbits is mediated by interleukin-8-dependent mechanisms. J Clin Invest. 1995;96(1):107–16.

    CAS  PubMed Central  PubMed  Google Scholar 

  244. Mulligan MS, Jones ML, Bolanowski MA, Baganoff MP, Deppeler CL, Meyers DM, et al. Inhibition of lung inflammatory reactions in rats by an anti-human IL-8 antibody. J Immunol. 1993;150(12):5585–95.

    CAS  PubMed  Google Scholar 

  245. Kurdowska A, Noble JM, Steinberg KP, Ruzinski JT, Hudson LD, Martin TR. Anti-interleukin 8 autoantibody: interleukin 8 complexes in the acute respiratory distress syndrome. Relationship between the complexes and clinical disease activity. Am J Respir Crit Care Med. 2001;163(2):463–8.

    CAS  PubMed  Google Scholar 

  246. Krupa A, Kato H, Matthay MA, Kurdowska AK. Proinflammatory activity of anti-IL-8 autoantibody:IL-8 complexes in alveolar edema fluid from patients with acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2004;286(6):L1105–13.

    CAS  PubMed  Google Scholar 

  247. Ponath PD. Chemokine receptor antagonists: novel therapeutics for inflammation and AIDS. Expert Opin Investig Drugs. 1998;7(1):1–18.

    CAS  PubMed  Google Scholar 

  248. Mehta NM, Arnold JH. Genetic polymorphisms in acute respiratory distress syndrome: new approach to an old problem. Crit Care Med. 2005;33(10):2443–5.

    PubMed  Google Scholar 

  249. Floros J, Pavlovic J. Genetics of acute respiratory distress syndrome: challenges, approaches, surfactant proteins as candidate genes. Semin Respir Crit Care Med. 2003;24(2):161–8.

    PubMed  Google Scholar 

  250. Shanley TP, Wong HR. Molecular genetics in the pediatric intensive care unit. Crit Care Clin. 2003;19(3):577–94.

    CAS  PubMed  Google Scholar 

  251. Lin Z, Pearson C, Chinchilli V, Pietschmann SM, Luo J, Pison U, et al. Polymorphisms of human SP-A, SP-B, and SP-D genes: association of SP-B Thr131Ile with ARDS. Clin Genet. 2000;58(3):181–91.

    CAS  PubMed  Google Scholar 

  252. Nogee LM, Dunbar 3rd AE, Wert SE, Askin F, Hamvas A, Whitsett JA. A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N Engl J Med. 2001;344(8):573–9.

    CAS  PubMed  Google Scholar 

  253. Stuber F, Petersen M, Bokelmann F, Schade U. A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis. Crit Care Med. 1996;24(3):381–4.

    CAS  PubMed  Google Scholar 

  254. Mira JP, Cariou A, Grall F, Delclaux C, Losser MR, Heshmati F, et al. Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA. 1999;282(6):561–8.

    CAS  PubMed  Google Scholar 

  255. King LS, Nielsen S, Agre P. Aquaporin-1 water channel protein in lung: ontogeny, steroid-induced expression, and distribution in rat. J Clin Invest. 1996;97(10):2183–91.

    CAS  PubMed Central  PubMed  Google Scholar 

  256. Ma T, Fukuda N, Song Y, Matthay MA, Verkman AS. Lung fluid transport in aquaporin-5 knockout mice. J Clin Invest. 2000;105(1):93–100.

    CAS  PubMed Central  PubMed  Google Scholar 

  257. Song Y, Fukuda N, Bai C, Ma T, Matthay MA, Verkman AS. Role of aquaporins in alveolar fluid clearance in neonatal and adult lung, and in oedema formation following acute lung injury: studies in transgenic aquaporin null mice. J Physiol. 2000;525(Pt 3):771–9.

    CAS  PubMed Central  PubMed  Google Scholar 

  258. Song Y, Ma T, Matthay MA, Verkman AS. Role of aquaporin-4 in airspace-to-capillary water permeability in intact mouse lung measured by a novel gravimetric method. J Gen Physiol. 2000;115(1):17–27.

    CAS  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pediatric Critical Care Medicine, Department of Pediatric and Communicable Diseases, C.S. Mott Children’s Hospital, 1500 E. Medical Center Dr. F6790/SPC 5243, Ann Arbor, MI, 48103, USA

    Waseem Ostwani MD

  2. MICHR, University of Michigan Medical School, 2800 Plymouth Road Building 400, Ann Arbor, MI, 48109, USA

    Thomas P. Shanley MD

Authors
  1. Waseem Ostwani MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thomas P. Shanley MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thomas P. Shanley MD .

Editor information

Editors and Affiliations

  1. Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA

    Derek S. Wheeler

  2. Div. of Critical Care Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA

    Hector R. Wong

  3. Pediatric Critical Care Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA

    Thomas P. Shanley

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag London

About this chapter

Cite this chapter

Ostwani, W., Shanley, T.P. (2014). Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome (ARDS). In: Wheeler, D., Wong, H., Shanley, T. (eds) Pediatric Critical Care Medicine. Springer, London. https://doi.org/10.1007/978-1-4471-6356-5_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-6356-5_7

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-6355-8

  • Online ISBN: 978-1-4471-6356-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation